These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 4134543)

  • 41. Human lymphocyte-dependent antibody mediated cytotoxicity and direct lymphocyte cytotoxicity against non-HL-A antigens.
    Yust I; Wunderlich J; Mann DL; Rogentine GN; Leventhal B; Yankee R; Graw R
    Nature; 1974 May; 249(454):263-5. PubMed ID: 4275318
    [No Abstract]   [Full Text] [Related]  

  • 42. A typical MLC reactions in HL-A-typed related and unrelated pairs.
    Mempel W; Grosse-Wilde H; Albert E; Thierfelder S
    Transplant Proc; 1973 Mar; 5(1):401-8. PubMed ID: 4266667
    [No Abstract]   [Full Text] [Related]  

  • 43. The HL-A complex in kidney transplantation.
    Dausset J
    Clin Nephrol; 1974; 2(1):1-3. PubMed ID: 4274665
    [No Abstract]   [Full Text] [Related]  

  • 44. Lymphocyte activation and destruction in vitro in relation to MLC and HL-A.
    Eijsvoogel VP; du Bois R; Melief CJ; Zeylemaker WP; Raat-Koning L; de Groot-Kooy L
    Transplant Proc; 1973 Sep; 5(3):1301-7. PubMed ID: 4125685
    [No Abstract]   [Full Text] [Related]  

  • 45. The immunogenetics of the major histocompatibility chromosomal region in man.
    Seigler HF; Ward FE; Amos DB; Stickel DL
    Surgery; 1973 Aug; 74(2):190-7. PubMed ID: 4123937
    [No Abstract]   [Full Text] [Related]  

  • 46. Phenotypic expression of the main histocompatibility complex (DL-A) in randomly selected mongrel dogs. 3. Inhibition of the mixed leukocyte culture reaction during and after sensitization to skin allografts.
    Bachvaroff R; Ozaki A; Cannon FD; Mollen N; Blumenstock DA; Ayvazian JH; Ferrebee JW; Rapaport FT
    Transplant Proc; 1973 Dec; 5(4):1863-8. PubMed ID: 4272835
    [No Abstract]   [Full Text] [Related]  

  • 47. Outcome of kidney transplants and suppression of mixed leukocyte culture by plasma.
    Sengar DP; Opelz G; Terasaki PI
    Transplant Proc; 1973 Mar; 5(1):641-7. PubMed ID: 4266671
    [No Abstract]   [Full Text] [Related]  

  • 48. The major histocompatibility complex--genetics and biology. (First of three parts).
    Bach FH; van Rood JJ
    N Engl J Med; 1976 Oct; 295(15):806-13. PubMed ID: 60701
    [No Abstract]   [Full Text] [Related]  

  • 49. Workshop summary on genetic determinants of cell-mediated immune reactions in the mouse.
    Festenstein H; Démant P
    Transplant Proc; 1973 Dec; 5(4):1321-7. PubMed ID: 4149543
    [No Abstract]   [Full Text] [Related]  

  • 50. Donor recipient pairing: an attempt to reconcile its theoretical power with its practical utility.
    Bach FH
    Clin Nephrol; 1974; 2(1):4-8. PubMed ID: 4150893
    [No Abstract]   [Full Text] [Related]  

  • 51. Human transplantation antigens. Appendix: current methods in histocompatibility testing.
    Kissmeyer-Nielsen F; Thorsby E
    Transplant Rev; 1969; 4():1-76. PubMed ID: 4110124
    [No Abstract]   [Full Text] [Related]  

  • 52. Transplantation, immunity, and disease: prerogatives of the HLA system.
    Amos DB
    Transplant Proc; 1977 Mar; 9(1):1335-41. PubMed ID: 405767
    [No Abstract]   [Full Text] [Related]  

  • 53. Genetic fine structure of the H-2 gene complex.
    Shreffler DC
    Soc Gen Physiol Ser; 1974; 29():83-100. PubMed ID: 4154504
    [No Abstract]   [Full Text] [Related]  

  • 54. Histocompatibility in the rabbit. Linkage between RL-A, MLC, and the He blood group loci.
    Tissot RG; Cohen C
    Transplantation; 1974 Aug; 18(2):142-9. PubMed ID: 4276720
    [No Abstract]   [Full Text] [Related]  

  • 55. Studies on the induction and expression of T cell-mediated immunity. 3. Amplification by papain of the generation of cytotoxic lymphocytes to allogeneic cells.
    Kedar E; Bonavida B
    J Immunol; 1974 Oct; 113(4):1386-9. PubMed ID: 4153487
    [No Abstract]   [Full Text] [Related]  

  • 56. Cellular immunity in the mouse. 3. In vitro kinetic studies on the relationship between recognition and effector phases.
    Phillips SM; Carpenter CB; Strom TB
    Transplant Proc; 1973 Dec; 5(4):1669-73. PubMed ID: 4130074
    [No Abstract]   [Full Text] [Related]  

  • 57. Histocompatibility determinants in multiple sclerosis.
    Jersild C; Dupont B; Fog T; Platz PJ; Svejgaard A
    Transplant Rev; 1975; 22():148-63. PubMed ID: 46643
    [No Abstract]   [Full Text] [Related]  

  • 58. [Use of leukocyte group typing in human organ transplantation].
    Botha MC
    Bibl Haematol; 1971; 37():39-52. PubMed ID: 4945043
    [No Abstract]   [Full Text] [Related]  

  • 59. [Immunological concepts relating to organ transplantation].
    Dei Poli G; Massa G; Rosso PA; Dei Poli N
    Minerva Chir; 1980 Jun; 35(11):829-78. PubMed ID: 6450338
    [No Abstract]   [Full Text] [Related]  

  • 60. Position of a locus determining mixed lymphocyte reaction distinct from the known HL-A loci.
    Eijsvoogel VP; van Rood JJ; Du Toit ED; Schellekens PT
    Eur J Immunol; 1972 Oct; 2(5):413-8. PubMed ID: 4263770
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.